JANE STREET GROUP, LLC - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$6,230
-58.0%
13,692
-38.2%
0.00%
Q2 2023$14,836
+85.4%
22,144
+113.0%
0.00%
Q2 2022$8,000
-42.9%
10,396
-32.9%
0.00%
Q4 2021$14,000
-80.6%
15,499
-44.7%
0.00%
Q1 2020$72,00028,0230.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q3 2022
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,873$26,0000.12%
GSA CAPITAL PARTNERS LLP 95,754$206,0000.03%
Arkadios Wealth Advisors 20,000$45,400,0000.02%
Bayesian Capital Management, LP 42,200$91,0000.02%
SeaCrest Wealth Management, LLC 50,515$109,0000.02%
Virtu Financial LLC 29,604$64,0000.01%
Traynor Capital Management, Inc. 14,777$31,0000.01%
WEDBUSH SECURITIES INC 13,295$29,0000.00%
Verition Fund Management LLC 40,000$86,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 11,600$25,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders